Insider Trading Activity For ResMed Inc. (NYSE:RMD)
James Hollingshead , Insider of ResMed Inc. (NYSE:RMD) reportedly Sold 1,600 shares of the company’s stock at an average price of 104.96 for a total transaction amount of $167,936.00 SEC Form
Analyst Ratings History For ResMed Inc. (NYSE:RMD)
- On 8/2/2017 Bank of America Downgraded rating Buy to Neutral
 - On 10/12/2017 Jefferies Financial Group Reiterated Rating Sell with a price target of $56.00
 - On 10/27/2017 Barclays Boost Price Target of rating Underweight with a price target of $68.00 to $70.00
 - On 1/23/2018 Macquarie Downgraded rating Neutral to Sell
 - On 1/23/2018 Northland Securities Upgraded rating Under Perform to Market Perform
 - On 3/7/2018 Needham & Company LLC Reiterated Rating Hold
 - On 4/4/2018 Citigroup Downgraded rating Buy to Neutral
 
Dividend Information For ResMed Inc. (NYSE:RMD)
ResMed Inc. (NYSE:RMD) pays an annual dividend of $1.48 with a yield of 1.42% 			and an average dividend growth of 7.50% (3 Year Average).
Dividend History For ResMed Inc. (NYSE:RMD)
Recent Trading Activity for ResMed Inc.  (NYSE:RMD)
Shares of ResMed Inc.  closed the previous trading session at     with  shares trading hands. 
                


